Delisting risk
Actinium Pharmaceuticals
Develops targeted radiotherapies for cancer and transplant conditioning.
$1.02
After-hours close+0.01 (+0.99%)
At close$1.01(+1.00%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.27 | — | — |
| Aug 2026 | $0.89 | $0.89 | 0.0% |
| May 2026 | −$0.22 | −$0.18 | +18.2% |
| Mar 2026 | −$0.19 | −$0.19 | −1.8% |
| Nov 2025 | −$0.25 | −$0.16 | +36.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| Apr 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Apr 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Jul 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Oct 2020 | |||
| Aug 2020 | |||
| Jun 2020 | |||
| May 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Oct 2016 | |||
| Jul 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Oct 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 13, 2026 | −$0.27 | — | — | $1.2M | — | — |
| Aug 7, 2026 | $0.89 | $0.89 | 0.0% | $35.0M | $35.0M | 0.0% |
| May 8, 2026 | −$0.22 | −$0.18 | +18.2% | $2.5M | — | — |
| Mar 30, 2026 | −$0.19 | −$0.19 | −1.8% | $600.0K | — | — |
| Nov 14, 2025 | −$0.25 | −$0.16 | +36.0% | $67.5K | $90.0K | +33.3% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 8, 2025 | ||||||
| May 9, 2025 | ||||||
| Mar 31, 2025 | ||||||
| Nov 14, 2024 | ||||||
| Aug 5, 2024 | ||||||
| Apr 26, 2024 | ||||||
| Mar 29, 2024 | ||||||
| Nov 2, 2023 | ||||||
| Aug 14, 2023 | ||||||
| May 15, 2023 | ||||||
| Apr 3, 2023 | ||||||
| Nov 14, 2022 | ||||||
| Aug 12, 2022 | ||||||
| May 13, 2022 | ||||||
| Mar 25, 2022 | ||||||
| Nov 12, 2021 | ||||||
| Jul 30, 2021 | ||||||
| May 14, 2021 | ||||||
| Mar 31, 2021 | ||||||
| Oct 23, 2020 | ||||||
| Aug 14, 2020 | ||||||
| Jun 30, 2020 | ||||||
| May 8, 2020 | ||||||
| Nov 12, 2019 | ||||||
| Aug 9, 2019 | ||||||
| May 10, 2019 | ||||||
| Mar 19, 2019 | ||||||
| Nov 9, 2018 | ||||||
| Aug 9, 2018 | ||||||
| May 10, 2018 | ||||||
| Mar 16, 2018 | ||||||
| Nov 3, 2017 | ||||||
| Aug 4, 2017 | ||||||
| May 15, 2017 | ||||||
| Mar 16, 2017 | ||||||
| Oct 28, 2016 | ||||||
| Jul 29, 2016 | ||||||
| May 10, 2016 | ||||||
| Mar 11, 2016 | ||||||
| Oct 30, 2015 | ||||||
| Aug 7, 2015 | ||||||